These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 19012201)

  • 1. [Prediction of perioperative mortality in patients with advanced liver disease and abdominal surgery by the use of different scoring systems and tests].
    Hofmann WP; Rädle J; Moench C; Bechstein W; Zeuzem S
    Z Gastroenterol; 2008 Nov; 46(11):1283-9. PubMed ID: 19012201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.
    Befeler AS; Palmer DE; Hoffman M; Longo W; Solomon H; Di Bisceglie AM
    Arch Surg; 2005 Jul; 140(7):650-4; discussion 655. PubMed ID: 16027329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
    Lee DH; Son JH; Kim TW
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
    Teh SH; Sheppard BC; Schwartz J; Orloff SL
    Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early and late outcome of cardiac surgery in patients with liver cirrhosis.
    Filsoufi F; Salzberg SP; Rahmanian PB; Schiano TD; Elsiesy H; Squire A; Adams DH
    Liver Transpl; 2007 Jul; 13(7):990-5. PubMed ID: 17427174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.
    Farnsworth N; Fagan SP; Berger DH; Awad SS
    Am J Surg; 2004 Nov; 188(5):580-3. PubMed ID: 15546574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-heart surgery in patients with liver cirrhosis: indications, risk factors, and clinical outcomes.
    An Y; Xiao YB; Zhong QJ
    Eur Surg Res; 2007; 39(2):67-74. PubMed ID: 17283429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis.
    Choi PC; Kim HJ; Choi WH; Park DI; Park JH; Cho YK; Sohn CI; Jeon WK; Kim BI
    Liver Int; 2009 Feb; 29(2):221-6. PubMed ID: 18544124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis.
    Corneille MG; Nicholson S; Richa J; Son C; Michalek J; Wolf SE; Stewart R
    J Trauma; 2011 Jul; 71(1):6-11. PubMed ID: 21818010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI; Lin HC; Wu JC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score.
    Cho HC; Jung HY; Sinn DH; Choi MS; Koh KC; Paik SW; Yoo BC; Kim SW; Lee JH
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):51-9. PubMed ID: 21084989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis.
    Zipprich A; Kuss O; Rogowski S; Kleber G; Lotterer E; Seufferlein T; Fleig WE; Dollinger MM
    Gut; 2010 Jul; 59(7):963-8. PubMed ID: 20581243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the MELD score predict perioperative morbidity for patients with liver cirrhosis undergoing laparoscopic cholecystectomy?
    Bingener J; Cox D; Michalek J; Mejia A
    Am Surg; 2008 Feb; 74(2):156-9. PubMed ID: 18306870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the Model of End-Stage Liver Disease].
    Ma H; Wang H; Sun Y; Guo F; Fang JL; Shao J; Rao HY; Wang J; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):407-9. PubMed ID: 15975270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of open heart surgery in patients with liver cirrhosis.
    Sugimura Y; Toyama M; Katoh M; Kato Y; Hisamoto K
    Asian Cardiovasc Thorac Ann; 2012 Jun; 20(3):263-8. PubMed ID: 22718713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.